NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated July 13, 2026

Oseltamivir

Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026

A neuraminidase inhibitor antiviral used for the treatment and prevention of influenza A and B. Most effective when started within 48 hours of symptom onset, reducing symptom duration by approximately 1-2 days and potentially reducing complications (pneumonia, hospitalization). Recommended by the CDC for high-risk patients with influenza, including the elderly, immunocompromised, pregnant women, and those with chronic medical conditions.

Evidence tier
Moderate
Indexed sources
10 2015–2025
Interactions
0
Category
Prescription
Read the sources → Compare profiles
Publication status

Exploratory record, not a reviewed medical publication.

See the editorial and medical-review policies for the publication gate.

This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.

In short

What the research says.

A quick, data-only summary. The full evidence, dosing, and sources are below.

A neuraminidase inhibitor antiviral used for the treatment and prevention of influenza A and B. NutriStack rates the supporting evidence as moderate. Common adult dosing is Treatment: 75 mg BID x 5 days (start within 48 hours of symptom onset); prophylaxis: 75 mg once daily x 10 days; pediatric dosing weight-based (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.

What it's good for
  • Reduces influenza symptom duration by 1-2 days1,2
  • Reduces risk of influenza-associated complications1,2
  • Post-exposure prophylaxis for influenza contacts1,2
  • Seasonal prophylaxis in high-risk populations8
  • Active against both influenza A and B1,2
What to watch for
  • Nausea and vomiting (most common)
  • Headache
  • Diarrhea
  • Known hypersensitivity to oseltamivir or any component1,2
  • Not a substitute for annual influenza vaccination1,2

The bottom line

Evidence rating moderate. Most-documented uses: reduces influenza symptom duration by 1-2 days, reduces risk of influenza-associated complications, post-exposure prophylaxis for influenza contacts. 10 sources indexed (2015–2025), with 0 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

A prodrug (ethyl ester) that is hydrolyzed by hepatic esterases to the active carboxylate form, oseltamivir carboxylate. The active metabolite competitively inhibits neuraminidase (sialidase), a glycoprotein enzyme on the surface of influenza A and B virions. Neuraminidase cleaves sialic acid residues on the host cell surface, which is essential for the release of newly formed virions from infected cells, spread to uninfected cells, and penetration of respiratory mucus. Inhibition results in viral aggregation on the cell surface and impaired spread.

Class
Neuraminidase Inhibitor Antiviral
Absorption
Water-soluble; take with food
Dosing

Dosing & protocol.

Common range
Treatment: 75 mg BID x 5 days (start within 48 hours of symptom onset); prophylaxis: 75 mg once daily x 10 days; pediatric dosing weight-based (as prescribed by your physician)
Recommended form
Oral capsules or oral suspension

Prodrug is well absorbed with approximately 80% bioavailability (as active carboxylate). Food does not reduce bioavailability but may reduce nausea. Can be taken with or without food.

Safety

Full safety detail.

Side effects

  • Nausea and vomiting (most common)
  • Headache
  • Diarrhea
  • Abdominal pain
  • Neuropsychiatric events (rare, delirium, hallucinations, abnormal behavior, primarily reported in pediatric patients in Japan)

Contraindications

  • Known hypersensitivity to oseltamivir or any component1,2
  • Not a substitute for annual influenza vaccination1,2
  • Severe renal impairment (CrCl <30 mL/min) requires dose adjustment
Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

5

Reference material

5
FAQ

Common questions.

Quick answers about Oseltamivir, drawn from the data on this page.

What is Oseltamivir?

A neuraminidase inhibitor antiviral used for the treatment and prevention of influenza A and B. Most effective when started within 48 hours of symptom onset, reducing symptom duration by approximately 1-2 days and potentially reducing complications (pneumonia, hospitalization). Recommended by the CDC for high-risk patients with influenza, including the elderly, immunocompromised, pregnant women, and those with chronic medical conditions.

What is Oseltamivir used for?

Commonly cited benefits of Oseltamivir include: Reduces influenza symptom duration by 1-2 days; Reduces risk of influenza-associated complications; Post-exposure prophylaxis for influenza contacts; Seasonal prophylaxis in high-risk populations; Active against both influenza A and B. NutriStack rates the overall evidence as moderate.

What is a typical dose of Oseltamivir?

A typical adult dose of Oseltamivir is Treatment: 75 mg BID x 5 days (start within 48 hours of symptom onset); prophylaxis: 75 mg once daily x 10 days; pediatric dosing weight-based (as prescribed by your physician). The commonly recommended form is Oral capsules or oral suspension. These are general ranges, not personalized advice; confirm the right dose with a clinician.

What are the side effects of Oseltamivir?

Reported side effects include nausea and vomiting (most common), headache, diarrhea, abdominal pain, neuropsychiatric events (rare, delirium, hallucinations, abnormal behavior, primarily reported in pediatric patients in japan). This is educational information; check with a healthcare professional before use.

How strong is the evidence for Oseltamivir?

NutriStack rates this as Moderate, meaning several aligned RCTs or one large RCT plus supporting reviews. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.

Use this with your stack

Oseltamivir in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

Download on the App Store → Read the methodology

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.